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Abstract There are over 150 known Sarcocystis species, and
at least one is capable of infecting and causing disease in man.
Extraintestinal (muscular) sarcocystosis and intestinal
sarcocystosis are the two known manifestations of disease in
humans. In this series of six cases and review, we focus on the
invasive extraintestinal (Bmuscular^) form of sarcocystosis in
humans. This disease, which until recently was rarely de-
scribed, has become relevant particularly as an imported con-
dition in travelers due to a recent series of outbreaks reported
from Malaysia. Human intestinal sarcocystosis is ubiquitous
across the globe. However, absolute numbers of probable and
particularly confirmed cases are few, with only several hun-
dred described to date. Characteristically, patients exhibit
signs and symptoms either 1–2 weeks after exposure, or after
4–8 weeks. Whether people remain asymptomatic or develop
disease apparently depends on the infecting species, host fac-
tors, and the inoculum size. The definitive host(s) remain un-
certain, and identification of the animal reservoir(s) requires
further research. A better understanding of the epidemiology
of the disease, as well as its immunological determinants, is
hampered by the lack of reliable serological diagnostic
methods. Additionally, DNA seems to be contained very ef-
fectively within the encysted parasite, thereby rendering PCR
detection unreliable. Physicians should suspect the condition
in patients with suggestive symptoms and a possible history of
exposure. Surveillance networks for imported infectious dis-
eases are formidable tools to help detect and localize
outbreaks.
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Biology, Epidemiological, Immunological,
and Clinical Features of Human Extraintestinal
Sarcocystosis in Brief
Out of the more than 150 known Sarcocystis species identified
so far, only one, Sarcocystis nesbitti, has been proven to date
of being capable of infecting and causing disease in man,
though others may exist. Human extraintestinal (muscular)
sarcocystosis is one of the two forms of illness man may
develop following ingestion of, and subsequent infection with
one of the species pathogenic to man [1••].
Sarcocystis spp. belong to the phylum of the Apicomplexa
(shared, e.g., with Toxoplasma gondii and Plasmodium spp.)
and are widely distributed throughout the world [1••]. This
organism requires a two-host predator (definitive host)-prey
(intermediate host) interaction to complete its life cycle. The
range of definitive hosts (those in which sexual replication
takes place in the gastrointestinal tract, resulting in intestinal
sarcocystosis) is broad and includes a variety of carnivorous
vertebrates, including humans. Following consumption of
sarcocyst-containing flesh, motile bradyzoites released in the
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small intestine by digestion enter the villous epithelium.With-
in enterocytes, sexual replication occurs, leading to the forma-
tion of sporocysts, which are passed in the feces. Sporocysts
ingested by a susceptible intermediate host from fecally con-
taminated food or water (typically herbi/omnivorous mam-
mals) undergo asexual phases of regeneration. Most classes
of vertebrates (including mammals, birds, reptiles/amphib-
ians, and possibly fish) [1••] can be suitable intermediate
hosts. Humans can also be infected in this manner, serving
as aberrant intermediate hosts. In the intermediate host, the
sporocysts excyst in the small intestine. Schizonts develop
within blood vessels, and the evolvingmerozoites invade skel-
etal, cardiac, and smooth muscles and develop into sarcocysts;
in case of infection of humans, we speak of extraintestinal or
muscular sarcocystosis. However, sarcocysts can also be
found sporadically in neural tissues of some animals [1••].
Human intestinal sarcocystosis has been reported from all
regions of the world except Africa and the Middle East. Ab-
sence from these regions is most likely related to
underdetection and underreporting rather than absence of
Sarcocystis spp. potentially pathogenic to man. Signs and
symptoms of intestinal sarcocystosis are usually limited to
acute and rarely chronic gastrointestinal symptoms. Whether
people remain asymptomatic or develop some degree of dis-
ease eventually requiring treatment (sulfa compounds and
others have been tried) may depend on the infecting species,
host factors, and inoculum size. Diagnosis of intestinal
sarcocystosis is based on coprological examination techniques
aimed at direct pathogen detection from feces; molecular de-
tection methods have played a limited role so far [2••]. Two
excellent recent comprehensive reviews describe all relevant
aspects of intestinal sarcocystosis [1••, 2••].
Below, we will be focusing on the invasive extraintestinal
(Bmuscular^) form of the disease in humans, as interest in this
till recently rarely encountered condition has grown as a result
of a recent series of outbreaks reported from islands in Malay-
sia (among others [3••, 4••, 5]). Given the extraordinary num-
ber of known Sarcocystis species in conjunction with a formi-
dably wide range of definitive and intermediate hosts, it is not
surprising that (similar to intestinal sarcocystosis) muscular
sarcocystosis cases have been reported from around the world.
However, for uncertain reasons, most cases are from Malay-
sia, with fewer cases from Africa and none from the Middle
East. In the case of extraintestinal human disease, in addition
to lack of detection as a possible explanation, prevalence of
Sarcocystis species capable of infecting humans as the inter-
mediate host in specific regions could be important. With
clearly less than 100 cases having been reported prior to the
recent outbreaks (an excellent synopsis of early cases had
been compiled by Beaver and colleagues [6•], while all more
recent individual cases and outbreaks have been summarized
by Fayer et al. [1••]), the dimension of the problem appeared
to be clearly limited in size, if not geographically. Preceding
the recent outbreaks, there was evidence that the Malaysian
archipelago is apparently a focus of transmission to, and hence
disease activity among humans, mostly if not exclusively in-
volving S. nesbitti.
Clinical signs and symptoms of symptomatic muscular
sarcocystosis are not well characterized. Of the 100 cases of
muscular sarcocystosis reported in the literature before the
recent outbreaks in Malaysia, no more than 10 symptomatic
individuals had been described. An additional 157 symptom-
atic persons have since been identified as part of the outbreaks
among tourists to islands in Malaysia. It is important to rec-
ognize that most symptomatic cases reported so far have been
among expatriates and travelers, suggesting a role of host
immunity in modulating disease manifestations in high-
prevalence regions. Disease manifestations may also depend
on the infecting species and the infective load. As summarized
by Fayer and colleagues [1••], clinical suspicion of muscular
sarcocystosis should be raised when encountering a patient
with travel or residency history in Southeast Asia, particularly
in Malaysia, in combination with fever and/or myalgia, ar-
thralgia, headache, fatigue, and a combination of less frequent
symptoms such as a rash. These represent compatible symp-
toms that might be encountered in an early phase of disease.
Later-phase disease may include more severe acute (often
circumscribed) myositis typically located in the thighs or the
facial/cervical region, often hallmarked by pain and swelling.
However, this myositis can occur in virtually all skeletal mus-
cles and (relative to the limited number of cases) also fairly
commonly in cardiac muscle.
As it will be described, diagnosis remains challenging, and
only the direct demonstration of sarcocysts in muscle offers
proof of infection. Molecular methods via PCR have limited
sensitivity and serological methods have been unreliable to
date [2••].
Not unexpected, with an extremely limited number of pa-
tients, no proper therapeutic trials could be conducted. Treat-
ment has included the administration of albendazole for 7–
14 days, with or without concurrent steroid [1••], but reported
responses may merely have reflected the natural course of the
disease. Treatment with trimethoprim/sulfamethoxazole (with
known antiprotozoal activity) early in the course of illness
may be promising as a potential therapy. However, in the
absence of good diagnostic criteria or laboratory testing and
adequate therapeutic trials, utility remains unproven. Adju-
vant treatment with corticosteroids and nonsteroidal anti-
inflammatory medications may help ameliorate symptoms.
Little is known about the immunology and the particulari-
ties of the host-parasite interplay of Sarcocystis spp. causing
extraintestinal disease in man. This is understandable, given
the limited number of cases described so far. What is evident
from reported cases is that human infection in susceptible
individuals elicits a strong eosinophilic and T cell-mediated
response. IgG production appears to be unreliable, or difficult
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to detect reliably; in any case, no convincing studies have been
conducted, and seroconversion in cases studied appears to be
erratic and hampered by cross-reactivity. The paucity of clin-
ical disease among residents in areas where outbreaks have
been noted amongst foreigners suggests that the infection
stimulates a humoral (yet T-cell-mediated) memory. However,
there is only one single case report in the literature [7] on an
AIDS patient in an advanced stage of immunosuppression
with concomitant sarcocystosis, manifesting itself atypically
as an acalculous cholecystitis; suggesting, apart from an eo-
sinophilic reaction, a role for T-cell-mediated defense. In
immune-competent individuals developing disease, the aver-
age cytokine production seems to decrease as a sign of early-
phase immunosuppression. In the later stage associated with
myositis, pro-inflammatory and chemotactic cytokines have
been found to be elevated in a series of travelers returning ill
from Tioman Island [8].
To fully understand the characteristic epidemiology of the
disease, with apparently few cases in local communities in
epidemiological foci but rather impressive attack rates in
expatriates/travelers to prevalence hotspots, further studies
are needed.
An Overview of the Recent Pangkor and Tioman
Island Outbreaks
Two recent outbreaks of symptomatic extraintestinal
sarcocystosis rapidly increased the number of documented
cases and served to deepen our knowledge of the clinical
spectrum of extraintestinal disease, but also highlighted our
continuing knowledge gaps. Unanswered questions continue
to be the exact risks and modes of transmission, the immunol-
ogy of the disease as determined in the host/pathogen inter-
play, and the optimal methods of diagnosis and treatment.
Italiano and colleagues [4••] reported on a group of 92
college students and their teachers who had been in a retreat
on Pangkor Island, off the west coast of the Malaysian penin-
sula, in January 2012. Of the 92, 89 (97 %) fell ill within
26 days, the majority within 9–11 days. The most likely com-
mon source of exposure was contaminated drinking water.
Most cases had fever (94 %) and myositis (91 %) as well as
headaches (87%), with less than 50% of patients complaining
of arthralgia or gastrointestinal symptoms. Of note, nine pa-
tients (10 %) suffered from transient swelling of masseter
muscles; only a few exhibited a transient rash (5 %). The
median duration of symptoms was 17 days, with non-
Malaysian patients requiring a longer time period to recovery
than Malaysians. In an early stage of disease, 32 % of patients
had elevated eosinophil counts, 60–70 % yielded moderately
elevated liver enzymes, and a minority (15 %) had an elevated
creatine phosphokinase (CPK). In a later phase, i.e., more than
4 weeks after the first possible time point of exposure,
eosinophilia was present in 67 % of cases, and 90 % of those
tested had an elevated CPK, while the proportion of patients
with moderately elevated liver enzymes remainedmore or less
unchanged. Sarcocysts were identified in three out of four
muscle biopsies, with PCR speciation yielding S. nesbitti in
all three cases. On the grounds of shared clinical features and
exposure, it was postulated that all patients likely had extrain-
testinal sarcocystosis, rendering this the biggest outbreak of
extraintestinal sarcocystosis reported to date. Symptoms re-
solved spontaneously in the vast majority of patients. Two
patients received corticosteroids, and in one patient, a specific
treatment attempt with sulfadoxine/pyrimethamine plus
clindamycin was made, without a clear correlation between
treatment and improvement of symptoms or normalization of
laboratory values.
Serological diagnosis was attempted on paired sera from
ten patients including those who were classified as Bdefinite
sarcocystis^ due to positivemicroscopy and/or PCR results; in
one of those cases, serology was negative.
The exposure investigation suggested accidental use of
contaminated untreated water from a nearby stream for prep-
aration of food and drink at the hotel where the retreat took
place.
Beginning early in 2011, and within 2 years, an increasing
number of travelers returning to their overseas home countries
presented with signs and symptoms of what soon was
suspected to constitute an outbreak of muscular sarcocystosis
amongst travelers to Tioman Island, off the east coast of the
Malaysian peninsula [3••, 5, 9–11]. Applying the case defini-
tion given in Table 2, 62 probable case patients and six pa-
tients confirmed by histological proof or DNA isolation from
muscle biopsy were seen in Europe, Canada, and Singapore
with complaints of myalgia (100 %), fatigue (91 %), fever
(82 %), and less frequently headache (59 %) and arthralgia
(29 %), with a distinct clustering into early (2 weeks after
departure from the island) and late (6 weeks after) phases,
and with CPK and blood eosinophilia levels rising distinctive-
ly in the second phase during the fifth week after departure.
The definitive diagnosis depends upon muscle biopsy, and
not even regularly so, as in only 6 out of 15 muscle biopsies,
sarcocysts were found. Ten patients underwent PCR testing of
their muscle biopsies, of which one (also positive on histolo-
gy) was positive and identified as S. nesbitti by sequence
analysis. Only a minority of patients could be definitely con-
firmed, rendering all other patients probable cases. No alter-
native diagnoses could be established. Although identification
of a common source of infection was not possible, all but one
patient was aware of potential exposure to untreated water.
Tappe and colleagues [12•] reviewed sarcocystosis in animals
in Malaysia and provide a comprehensive list of potential and
confirmed intermediate wild and domestic host species. A
resident snake species (the Indian or spectacled cobra (Naja
naja) has been suggested to be a natural definitive host for
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S. nesbitti [13–15]. Others such as the reticulated python have
been identified as definitive host for animal-infecting
Sarcocystis spp. [12•]), and for the time being, water contam-
ination appears to be the most likely source of infection. Of
note, an environmental investigation of the Malaysian Minis-
try of Health did not recover any Sarcocystis species from
sampled water sources in the most afflicted region [16].
A Closer Look at a Series of Extraintestinal
Sarcocystis Patients Encountered in the AMC
Tropencentrum
Between 2011and 2014, six patients presented to our outpa-
tient traveler’s clinic after a trip to Malaysia. They all had
visited the island of Tioman, Malaysia. All patients were rel-
atively young with no significant medical history. Shared po-
tential risk factors were as follows: contact with sea water and
beaches, potential contact with contaminated drink and/or
food sources, and recollection of noting undomesticated cats.
After their return, back to the Netherlands, two of the pa-
tients developed complaints shortly (within 2 weeks) after
exposure and the four others up to 3 months after exposure.
The patients developed varying complaints, ranging from fe-
ver to general malaise and slowly progressive exhaustion with
muscle aches, continued itching without a skin rash, shortness
of breath, diminished physical condition, and weight loss.
Physical examination revealed few diagnostic clues; how-
ever, most patients appeared fatigued and demonstrated ex-
haustion during minimal exertion.
Initial laboratory results showed elevated CPK, alanine
aminotransferase (ALAT), and lactate dehydrogenase (LDH)
and slightly elevated C-reactive protein (CRP) and erythrocyte
sedimentation rate (ESR) in combination with an eosinophilia.
In two patients, the eosinophilia was not present initially;
however, it developed within 2 weeks. Of note, these two
patients had highly elevated CPK levels on presentation. In
all six patients, further microbiologic testing has been per-
formed and all additional tests performed in selected patients
(i.e., not all tests were conducted in all patients—
trichinellosis, toxoplasmosis, toxocariasis, strongyloidiasis,
schistosomiasis, filariasis, paragonimiasis and cysticercosis,
dengue and chikungunya, and rickettsiosis) turned out to be
negative. All patients had negative trichinellosis serology.
Some imaging studies were performed, all with no abnormal-
ities. Key features of all six patients are summarized in
Table 1.
During our first patient’s evaluation (see Case Vignette),
GeoSentinel/EuroTravNet (the Global [17] and European
[18] Surveillance Networks of the International Society for
Travel Medicine (ISTM)), TropNet (another former surveil-
lance, now research network focusing on Europe) [19] and the
Centers for Disease Control (CDC) issued preliminary reports
of Sarcocystis infection in travelers returning from Tioman
Island, Malaysia, after travel between June and August of
2011. Most travelers had complaints of muscle pain, elevated
CPK and eosinophilia. Attempting to determine if our patient
was suffering from a Sarcocystis infection, we performed a
muscle biopsy in October 2011, showing myositis with eosin-
ophil infiltration, but not sarcocysts (Fig. 1a–d).
Muscle biopsies were also performed on two other patients.
In one patient, the biopsy showed the presence of sarcocysts
without prominent infiltrates, whereas in the other patient the
biopsy showed myositis with eosinophil infiltration. but not
sarcocysts in situ (Fig. 2a–d).
According to the Geosentinel and CDC case definition for
Sarcocystis (see Table 2), our patients had probable acute
muscular sarcocystosis. All were empirically treated with
albendazole 400 mg BID/7–10 days (two of them received
prednisone, 20 mg orally over 5 days each), and all recovered
with complete resolution of all symptoms and normalization
of the laboratory values, with no alternative diagnoses
determined.
Case Vignette
Mr. B was a 48-year-old man who presented to us approxi-
mately 3 months after a trip to Malaysia with complaints of
muscle pain, itching, and shortness of breath.
The patient’s past medical history was significant only for
an appendectomy and the diagnosis of irritable bowel syn-
drome 3 years prior to presentation. He had been vaccinated
against diphtheria, tetanus and pertussis, hepatitis A, and Sal-
monella typhi several months prior to his travel.
The patient began his travels on 19 July 2011 when he flew
fromAmsterdam, the Netherlands, to Dubai in the Arab Emir-
ates with his two children. They spent 2 days enjoying the
beach and shopping before continuing on to Bangkok, Thai-
land, on 21 July. In Bangkok, the patient visited temples and
ate local food. On 27 July, the family flew through Kuala
Lumpur and onto the island of Tioman, Malaysia. There they
stayed in a hotel resort for 9 days. They spent the majority of
their time on the beach and swam and snorkeled in salt water.
The patient flew back to Amsterdam on August 4, 2011.
On August 20, 2011—2 weeks after his return to Amster-
dam—he developed general malaise and slowly progressive
exhaustion. Around September 10—a little more than 1month
after his return—he noted night sweats, generalized pruritus,
and muscle aches throughout his entire body. On September
20—6 weeks after his return—he developed a fever up to
38.5 °C and noticed shortness of breath on exertion and diz-
ziness upon standing. On October 4—2 months after his re-
turn—he presented to our travelers outpatient clinic with con-
tinued pruritus without a skin rash, muscle aches, shortness of
breath on minimal exertion, postural dizziness, occasional
stabbing chest pain, and 2 kg of weight loss.
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On physical examination, the patient was moderately ill-
appearing with tachypnea to 28 breaths per minute on exer-
tion. His oxygen saturation was 100 % on room air, sitting
blood pressure was 110/70 mmHg with a pulse of 60 beats per
minute and dropped to 90/64 mmHg on standing with a pulse
increase to 96 bpm. The remaining physical examination was
completely normal except for pain on deep palpation of the
right upper quadrant without rebound tenderness.
Initial laboratory results were as follows: CRP 25 mg/L;
bilirubin 5 μmol/L; aspartate aminotransferase (ASAT) 33 U/
L; ALAT 55 U/L; alkaline phosphatase 60 U/L; LDH 271 U/
L; CPK 275 U/L; leukocytes 9.2×109/L (eosinophils 1.38×
109/L=15 %); hemoglobin (Hb) 10.0 mmol/L; mean corpus-
cular volume (MCV) 87 fL; thrombocytes 31×109/L; D-
dimers 2.50 mg/L). CK-MB (muscle-brain) and cardiac tro-
ponin measurements were negative.
Imaging studies were performed. A chest X-ray and CT of
the thorax were performed—these showed no pulmonary in-
filtrates, no sign of a pulmonary embolism, and no lymphade-
nopathy. An abdominal echo demonstrated a normal liver,
gallbladder, spleen, and kidneys. An ECG showed sinus
rhythm, normal conduction, and no signs of hypertrophy or
ischemia. Because of the patient’s continued complaints of
exertional dyspnea, a cardiac echo was performed which
Fig. 1 Muscle biopsy of patient
#1. a Hematoxylin and eosin
(HE) stain showing an
endomysial inflammatory cell
infiltrate with eosinophils
(arrows). b (CD3) T lymphocytes
with invasion of muscle fibers. c
(CD68) macrophages. d (CD20)
B lymphocytes. Scale bars,
40 μM
Fig. 2 Muscle biopsies of
patients #1 and #3. a–b
Hematoxylin and eosin (HE) stain
showing sarcocysts within the
muscle fibers. cMajor
histocompatibility complex class
II (MHC II): inflammatory cell
infiltrate around sarcocyst
(asterisk). d HE stain showing
endomysial inflammatory cell
infiltrate with eosinophils
(arrows). Scale bars, a–c 40 μM;
d 160 μM
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showed normal left ventricular systolic function, a dilated
right ventricle with a minimal tricuspid insufficiency.
Microbiologic test included triple feces tests (twice); blood
cultures (twice), and Strongyloides, Fasciola, Filaria,
Toxocara, Trichinella, Toxoplasma, HIV, CMV, and EBV se-
rologies. Except for a positive IgG for EBV, all tests/
serologies were negative. Since more than 6 weeks had passed
after return, the patient presented beyond the time frame to
consider dengue or chikungunya virus infection.
During the patient’s evaluation, the GeoSentinel (the Global
Surveillance Network of the International Society for Travel
Medicine (ISTM) program director gave a preliminary report of
Sarcocystis infection in travelers returning from Tioman Island,
Malaysia, after travel between June and August of 2011. Most
travelers had complaints of muscle pain, elevated CPK and eo-
sinophilia, withmany features sharedwith our patient. In order to
determine whether our patient was suffering from a Sarcocystis
infection, we performed a muscle biopsy in October 2011.
The muscle biopsy (Fig. 1) showed inflammatory cell in-
filtrate within the endomysium composed of eosinophils, T
lymphocytes (with invasion of muscle fibers), macrophages,
and few B lymphocytes. The muscle biopsy tissue blocks
were subsequently shipped to the CDC Infectious Diseases
Pathology Branch for additional examination, including his-
topathology, polymerase chain reaction (PCR) detection, and
DNA sequencing analysis of Sarcocystis spp. 18S rRNA
amplicons. These were all negative. However, given the high-
ly unusual finding of an eosinophilic myositis (also found in
the other two cases in whom biopsy was performed), the pa-
thology reports were interpreted as highly suggestive for an
invasive sarcocystis infection.
Our patient was empirically treated with 7 days of
albendazole 10 weeks after return, and by 14–16 weeks after
his return to the Netherlands, he had complete resolution of all
symptoms and normalization of both his eosinophilia and his
CK. It is uncertain if his recovery was representative of the
normal course of disease or perhaps influenced by the
albendazole. A last interesting detail in the course of his dis-
ease was the development of a subcutaneous nodule on his left
calf 20 weeks after his return, with spontaneous resolution,
and as described before in one of the patients from the Tioman
Island case series [3••].
According to the recent GeoSentinel and CDC case defini-
tion for sarcocystis [3••] (Table 2), our patient had probable
acute muscular sarcocystosis. In the recent Tioman Island case
series review [3••], patient symptoms seemed to occur in two
distinct phases—early (after the second week of exposure)
and late (after the sixth week of exposure). This patient’s
symptoms began 2 weeks after his return from Tioman and
he appeared to have peak muscle complaints approximately
6 weeks after his return, suggesting a possible immune-
mediated myositis. His case is particularly interesting because
of his predominant complaints of dyspnea on exertion and
chest pain in combination with postural hypotension and a
dilated right ventricle on echocardiography, suggesting possi-
ble Sarcocystis or immune involvement of his heart; and the
subcutaneous nodule appearing and resolving spontaneously.
This overall small series of patients of which patient #1 was
included in the Esposito et al. case compilation [3••] high-
lights many of the common features of probable muscular
sarcocystosis but also highlights the diagnostic difficulties en-
countered in confirming the diagnosis.
Human Sarcocystosis: What Are the Knowledge
Gaps?
Although the latest outbreaks contribute significantly to our
knowledge, several matters remain unresolved. Firstly, al-
though it is apparent that S. nesbitti seems to form a preva-
lence epicenter around the Malaysian peninsula, the global
epidemiology of (particularly) extraintestinal sarcocystosis re-
mains patchy and unclear. With a Bsupershedder^ remaining
unidentified but suspected in Indian cobras and maybe other
snakes, a single definitive host may be responsible for high
numbers of patients in very circumscribed areas. It would be
of great interest with possible public health implications to
pursue identification of this (or multiple, regionally highly
infested) animal reservoir(s). With Sarcocystis species defi-
nitely or potentially infectious to man as an aberrant interme-
diate host, it remains unclear whether sporadic cases or even
epidemic clusters were missed due to plausible alternative
diagnoses (or ignorance), or whether geographical distribution
is as distinct as it appears.
Of note, the fascinating immunology and host/parasite in-
terplay remain by-and-large to be elucidated, which is much
needed to fully understand the epidemiologic characteristics
of the disease, with few cases in local populations but out-
breaks among expatriates/travelers to particular foci. Better
Table 2 Definition of probable and confirmed sarcocystosis as handled
by GeoSentinel and CDC
Probable acute muscular sarcocystosis
- Travel to Tioman Island after March 1, 2011
- Myositis (requiring at least one of the following):
▪ A complaint of muscle pain and a CPK level >200 international units
per liter (IU/L)
▪ Muscle tenderness documented on physical examination
▪ Histologic evidence of myositis in a muscle biopsy
- Eosinophilia >500 cells per microliter (cells/μL)
- Negative Trichinella serology
Confirmed acute muscular sarcocystosis
- Histologic observation of intramuscular cysts compatible with
sarcocysts or the isolation of Sarcocystis spp. DNA from a muscle
biopsy.
Source: Esposito et al. [3••]
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understanding of the epidemiology of the disease is of utmost
importance as there is evidence that the local population [2••]
is probably more frequently able to contain infection at sub-
clinical levels. However, this hampered by the lack of reliable
diagnostic methods. To that end, Sarcocystis species pose for-
midable diagnostic challenges in extraintestinal disease. At
this point in time, there is little evidence that this will be easily
overcome in the near future, pinpointing the need for a high
level of clinical suspicion, and exclusion of potential differen-
tial diagnoses, to reliably identify patients. It has been shown
that in situations outside a clustering in a Breal^ outbreak such
as on Pangkor Island, surveillance networks for imported in-
fectious diseases are powerful tools to detect hyperendemic
areas or ongoing outbreaks. Surveillance networks are also of
particular importance in detecting cases of this disease that
appears to be more pronounced in travelers than in locals. It
appears to be wishful for the sake of the patients that physi-
cians include, despite the paucity of cases, extraintestinal
sarcocystosis in their differential diagnosis of patients with a
possible history of exposure, a suggestive clinical picture of
myositis and accompanying signs and symptoms.
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